Trial Profile
A Study of the Safety and Antiviral Activity of Open-Label Entecavir (BMS-200475) in Adults With Chronic Hepatitis B Infection Who Have Completed Dosing in a Previous Phase II/III Study in China.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Apr 2013
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Registrational
- Sponsors Bristol-Myers Squibb
- 15 Sep 2009 New trial record